Infinity Medicald's portfolio company CytoReason, a leading developer of computational disease models for efficient drug discovery and development, today announced the extension of its collaboration agreement with Pfizer!
Nanomedic has developed an innovative and first-of-its-kind device - “Electrospinning Portable”, for the treatment and healing of complex burns and wounds by using a polymer matrix printed on the patient himself in real time, that acts as temporary skin until the wound heals completely.
China’s Capital Market: The Main Growth Engine of 2020s Foreign Capital Opportunities in China and CICC Capital Markets Case Study: Electric Cars & Medical Trends Capital Markets Investment Opportunities & IMED INFINITY MEDICAL
